Onward Medical N.V.
ONWRF
$5.70
-$0.42-6.86%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 672.40K | 623.50K | 816.00K | 841.60K | 111.90K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 672.40K | 623.50K | 816.00K | 841.60K | 111.90K |
| Cost of Revenue | 3.42M | 3.17M | 3.85M | 3.97M | 3.60M |
| Gross Profit | -2.75M | -2.55M | -3.03M | -3.13M | -3.48M |
| SG&A Expenses | 6.85M | 6.35M | 4.44M | 4.58M | 5.16M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.01M | 11.13M | 9.39M | 9.69M | 10.20M |
| Operating Income | -11.33M | -10.51M | -8.58M | -8.85M | -10.09M |
| Income Before Tax | -11.92M | -11.05M | -9.16M | -9.45M | -9.99M |
| Income Tax Expenses | 102.10K | 94.70K | 148.20K | 152.80K | -171.10K |
| Earnings from Continuing Operations | -12.02M | -11.14M | -9.31M | -9.60M | -9.82M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.02M | -11.14M | -9.31M | -9.60M | -9.82M |
| EBIT | -11.33M | -10.51M | -8.58M | -8.85M | -10.09M |
| EBITDA | -11.07M | -10.26M | -8.49M | -8.71M | -9.86M |
| EPS Basic | -0.27 | -0.25 | -0.17 | -0.18 | -0.28 |
| Normalized Basic EPS | -0.17 | -0.15 | -0.10 | -0.11 | -0.18 |
| EPS Diluted | -0.27 | -0.25 | -0.17 | -0.18 | -0.29 |
| Normalized Diluted EPS | -0.17 | -0.15 | -0.10 | -0.11 | -0.18 |
| Average Basic Shares Outstanding | 44.64M | 44.64M | 54.63M | 54.63M | 34.63M |
| Average Diluted Shares Outstanding | 44.64M | 44.64M | 54.63M | 54.63M | 34.63M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |